Modern biotechnology extends far beyond traditional laboratory research. Companies now work with genome editing, cell and gene therapy, synthetic biology, RNA technologies, protein engineering, computational biology, automation and AI-assisted discovery.

The biotechnology sector is also becoming increasingly interdisciplinary. Recent research highlights growing convergence between gene editing, cell and gene therapy, immunotherapy and artificial intelligence.

What Is a Biotechnology Company?

A biotechnology company is an organization that applies biological knowledge and technologies to research, development, manufacturing or scientific problem-solving.

Depending on its focus, a biotechnology company may work with:

• DNA and RNA
• Genes and genomes
• Cells and tissues
• Proteins and enzymes
• Microorganisms
• Biological medicines
• Vaccines
• Agricultural organisms
• Fermentation systems
• Synthetic biological systems
• Computational biological data

Some companies concentrate on a single research area, while others combine several biotechnology platforms.

How Does a Biotechnology Company Work?

Although workflows vary, many biotechnology organizations follow a research and development cycle.

1. Research

Scientists investigate a biological mechanism, disease pathway, organism, molecule or technological problem.

2. Discovery

Researchers identify promising biological targets, molecules, genes, cells or processes.

3. Development

The selected concept is developed into a more defined experimental platform or candidate.

4. Laboratory Testing

Researchers evaluate biological activity, safety, performance and reproducibility.

5. Preclinical Research

For therapeutic technologies, promising candidates may undergo laboratory and preclinical evaluation before human studies.

6. Clinical Development

Eligible medical candidates progress through regulated clinical research involving human participants.

7. Manufacturing Development

The organization establishes processes capable of producing consistent biological materials or products.

8. Regulatory Review

Relevant regulatory authorities evaluate products according to their category, intended use and applicable regulations.

9. Monitoring

Biological products can require continued monitoring after authorization or introduction.

The exact pathway differs significantly between medicines, diagnostics, agricultural biotechnology, food biotechnology and industrial applications.

Major Types of Biotechnology Companies

Biotechnology is often described using broad application categories.

Red Biotechnology

Red biotechnology focuses primarily on healthcare and medicine.

Areas include:

• Therapeutic research
• Vaccines
• Gene therapy
• Cell therapy
• Immunotherapy
• Diagnostics
• Regenerative medicine
• Biologics
• Molecular testing

This is one of the most visible areas of modern biotechnology.

Green Biotechnology

Green biotechnology applies biological technologies to agriculture and plant science.

Examples include:

• Crop improvement
• Plant biotechnology
• Pest resistance
• Disease resistance
• Trait development
• Agricultural diagnostics
• Microbial agriculture
• Sustainable farming technologies

White or Industrial Biotechnology

Industrial biotechnology uses microorganisms, enzymes and biological processes for industrial applications.

Examples include:

• Bio-based chemicals
• Enzymes
• Fermentation
• Biomaterials
• Biofuels
• Industrial ingredients
• Biomanufacturing

Blue Biotechnology

Blue biotechnology focuses on marine and aquatic biological resources.

Applications can include:

• Marine organisms
• Aquatic biotechnology
• Marine enzymes
• Algae research
• Biomaterials
• Aquaculture technologies

Environmental Biotechnology

Environmental biotechnology uses biological systems to address environmental challenges.

Applications include:

• Waste treatment
• Bioremediation
• Pollution monitoring
• Biological filtration
• Resource recovery
• Sustainable production systems

Core Technologies Used by Biotechnology Companies

Genetic Engineering

Genetic engineering involves modifying genetic material to investigate biological processes or produce desired characteristics.

It can support research involving:

• Gene function
• Protein production
• Disease mechanisms
• Engineered microorganisms
• Therapeutic development

CRISPR and Genome Editing

CRISPR-based systems have become important tools for programmable genome modification.

Newer approaches extend beyond conventional DNA cutting. Base editing, prime editing and RNA-editing technologies are being investigated for more precise biological modifications.

Potential areas include:

• Genetic disease research
• Functional genomics
• Cell engineering
• Therapeutic development
• Agricultural research

However, delivery, editing specificity, immune responses and long-term safety remain important scientific considerations.

Cell Culture

Cell culture allows researchers to grow and study cells under controlled laboratory conditions.

It is widely used in:

• Drug research
• Vaccine development
• Cancer research
• Cell therapy
• Toxicology
• Biological testing

Protein Engineering

Protein engineering modifies or designs proteins to achieve particular biological or industrial characteristics.

Applications include:

• Enzymes
• Therapeutic proteins
• Antibodies
• Diagnostics
• Industrial biotechnology

Synthetic Biology

Synthetic biology combines biological science with engineering principles to design or redesign biological systems.

Researchers may develop:

• Engineered cells
• Genetic circuits
• Microbial production systems
• Biological sensors
• Programmable biological systems

Emerging research is also exploring engineered living cells as biological delivery systems, where cells can sense specific environments and release therapeutic molecules.

RNA Technologies

RNA has become an important biotechnology platform.

Research areas include:

• Messenger RNA
• RNA vaccines
• RNA therapeutics
• RNA editing
• Gene regulation
• RNA-based diagnostics

Sequencing and Genomics

DNA and RNA sequencing allow researchers to examine biological information at increasingly detailed levels.

Applications include:

• Genome analysis
• Disease research
• Precision medicine
• Microbial identification
• Population studies
• Biomarker research

Artificial Intelligence in Biotechnology

AI is increasingly being integrated into biological research.

Potential applications include:

• Protein structure analysis
• Molecular design
• Drug discovery
• Genomic analysis
• Medical imaging
• Biomarker identification
• Laboratory automation
• Experimental planning
• Biological data interpretation

Multimodal AI can combine different forms of information, including genomic, clinical and imaging data, potentially producing broader biological insights.

However, AI should not automatically be viewed as a replacement for laboratory validation.

A 2026 review of AI in drug discovery notes that evidence of clinically meaningful impact remains limited in many areas and emphasizes the importance of relevant data, appropriate validation and real-world decision-making.

Biotechnology and Drug Discovery

Drug discovery is one of the largest areas where biotechnology and computational science intersect.

A simplified discovery workflow may include:

Disease Understanding → Target Identification → Candidate Discovery → Laboratory Testing → Preclinical Research → Clinical Development → Regulatory Review

Biotechnology can contribute at several points in this process.

Target Identification

Scientists investigate biological molecules or pathways associated with a disease.

Screening

Large numbers of molecules or biological candidates can be evaluated to identify promising candidates.

Molecular Design

Computational approaches can help researchers investigate potential molecular structures.

Biomarker Research

Biomarkers can help researchers understand disease processes or evaluate responses to treatments.

Precision Medicine

Genomic and molecular information can potentially help researchers classify diseases and investigate more targeted approaches.

Cell and Gene Therapy

Cell and gene therapy represents an important biotechnology field.

Gene therapy generally involves introducing, modifying or regulating genetic material, while cell therapy uses cells to restore, replace or enhance biological functions.

Modern genome-editing research is expanding from conventional CRISPR nucleases toward base editing, prime editing and RNA editing.

The field has also moved beyond early experimental stages. A 2026 Nature Medicine editorial noted that more than 50 gene therapies had received approval globally, while emphasizing continuing challenges involving safety, manufacturing and adoption.

Biotechnology Applications Across Industries

Biotechnology in Agriculture

Agricultural biotechnology can help scientists investigate and develop improved biological characteristics.

Areas include:

• Crop genetics
• Plant disease research
• Molecular breeding
• Biological pest management
• Microbial soil technologies
• Trait development
• Plant diagnostics

Biotechnology can also intersect with sustainable agriculture by exploring biological alternatives and improving resource efficiency.

Biotechnology in Food and Fermentation

Microorganisms have been used in food production for thousands of years, but modern biotechnology allows researchers to study fermentation and biological production at a much more detailed level.

Applications include:

• Fermented foods
• Enzymes
• Food ingredients
• Precision fermentation
• Alternative proteins
• Microbial production

Precision fermentation is an emerging area where microorganisms are engineered or optimized to produce particular proteins, molecules or ingredients.

Environmental Biotechnology

Environmental biotechnology applies biological processes to environmental challenges.

Bioremediation

Microorganisms or biological processes can be used to break down or transform certain contaminants.

Waste Treatment

Biological processes can support wastewater and organic-waste treatment.

Resource Recovery

Researchers are investigating ways to recover useful materials from biological and industrial waste streams.

Biological Monitoring

Biological indicators and molecular techniques can help researchers monitor environmental conditions.

Biotechnology Research Infrastructure

Biotechnology companies often require specialized infrastructure.

Common components include:

• Molecular biology laboratories
• Cell culture facilities
• Sequencing systems
• Analytical instruments
• Bioreactors
• Controlled environments
• Refrigerated storage
• Data systems
• Laboratory automation
• Quality-control laboratories

The infrastructure depends heavily on the company's research focus.

Biomanufacturing

Biomanufacturing uses biological systems to produce biological or bio-based materials.

Production platforms can include:

• Bacterial cells
• Yeast
• Mammalian cells
• Insect cells
• Plant systems
• Cell-free systems

Biomanufacturing can be particularly complex for advanced therapies because production consistency, contamination control, process validation and specialized handling are important.

Challenges Facing Biotechnology Companies

Scientific Uncertainty

Biological systems are highly complex, and laboratory results do not always translate directly into successful real-world outcomes.

Safety

New biological technologies can introduce unknown risks that require careful evaluation.

Regulatory Complexity

Biotechnology spans multiple sectors and regulatory categories. Different jurisdictions may apply different requirements.

The OECD's 2026 analysis identifies regulatory uncertainty, fragmentation, complexity and lengthy approval processes among important challenges affecting biotechnology innovation.

Manufacturing

Scaling a biological process from laboratory experiments to reliable production can be difficult.

Data Quality

AI and computational biology depend heavily on the quality, diversity and relevance of biological datasets.

Reproducibility

Experiments need appropriate controls, validation and reproducible methods.

Ethical Considerations

Genetic modification, human biological data, embryo research, synthetic biology and AI-assisted biological design can raise significant ethical questions.

Regulation and Biosafety

Biotechnology research and products may be subject to different regulatory systems depending on the technology and application.

Important areas can include:

• Laboratory biosafety
• Biological containment
• Human research ethics
• Clinical trial requirements
• Genetic data protection
• Product quality
• Environmental considerations
• Manufacturing controls
• Regulatory authorization

Organizations working with biotechnology therefore need appropriate scientific, ethical, quality and regulatory processes.

Because requirements differ by country and technology, researchers should consult the relevant national authorities and current regulations rather than relying on a general biotechnology framework.

Recent Biotechnology Industry Insights

AI and Biological Data

Biological AI is moving toward models capable of working across DNA, RNA, proteins and cellular systems. Researchers are exploring whether these systems can eventually support more integrated biological prediction and experimental design.

Gene Editing Beyond CRISPR-Cas9

The biotechnology field is expanding beyond traditional CRISPR-Cas9 approaches toward base editing, prime editing and RNA editing. These technologies may provide alternative ways to modify biological information.

Gene Therapy Delivery

Delivery remains one of the major challenges for DNA- and RNA-based therapies. Researchers continue to investigate methods that can deliver biological payloads to appropriate tissues while maintaining safety and minimizing unwanted immune responses.

Synthetic Biology and Living Systems

Synthetic biology is increasingly intersecting with AI and engineering to develop programmable biological systems, including research into engineered cells for targeted therapeutic delivery.

Global Biotechnology Policy

The biotechnology sector is receiving increasing policy attention because of its potential impact on healthcare, agriculture, industrial production, sustainability and economic development. The OECD's 2026 work highlights workforce skills, patents, financing, manufacturing capacity and regulatory frameworks as important parts of biotechnology innovation ecosystems.

Future of Biotechnology Companies

The future biotechnology landscape is likely to be shaped by greater convergence between biology, engineering and computing.

Important areas to watch include:

• AI-assisted biological research
• Precision genome editing
• RNA technologies
• Cell and gene therapy
• Synthetic biology
• Protein design
• Automated laboratories
• Digital biology
• Biological foundation models
• Precision medicine
• Advanced biomanufacturing
• Sustainable biotechnology

One emerging direction is the development of more general biological AI systems that can analyze and generate information across multiple biological levels rather than focusing on one isolated task.

However, scientific validation will remain essential. Biotechnology involves real biological systems, so computational predictions generally need appropriate experimental testing before they can support high-stakes decisions.

How to Evaluate a Biotechnology Company

When researching a biotechnology company, consider:

Research Focus

What biological problem or scientific area does the organization investigate?

Technology Platform

Does it specialize in genome editing, cell biology, synthetic biology, AI, diagnostics, biologics or another platform?

Research Stage

Is the work exploratory, preclinical, clinical, manufacturing-focused or already established?

Scientific Evidence

What peer-reviewed research, experimental evidence or validated results support the technology?

Regulatory Position

What approvals, authorizations or research permissions apply?

Manufacturing Capability

Can the organization translate laboratory research into reproducible production?

Intellectual Property

What patents, proprietary platforms or research methods support its technology?

Partnerships

Biotechnology development can involve collaboration between academic institutions, research organizations, technology companies and healthcare organizations.

Biotechnology Company vs Pharmaceutical Company

The terms biotechnology company and pharmaceutical company can overlap.

The distinction is not absolute. Many large pharmaceutical organizations conduct extensive biotechnology research, while biotechnology companies can develop and manufacture medicines.

Frequently Asked Questions

What does a biotechnology company do?

A biotechnology company uses biological science and technologies to research, develop or produce solutions involving genes, cells, proteins, microorganisms or biological systems.

What technologies are used by biotechnology companies?

Common technologies include genetic engineering, genome editing, cell culture, sequencing, protein engineering, synthetic biology, RNA technologies, fermentation and AI-assisted biological analysis.

Are biotechnology companies only involved in healthcare?

No. Biotechnology also has applications in agriculture, food, industrial manufacturing, environmental science and marine research.

How is AI changing biotechnology?

AI can help analyze biological datasets, investigate molecular structures, identify patterns, support experimental planning and explore drug discovery. However, current evidence suggests that AI's real-world impact still depends heavily on data quality, validation and appropriate experimental integration.

What are the major challenges in biotechnology?

Major challenges include scientific uncertainty, safety, regulatory complexity, manufacturing scale-up, data quality, reproducibility, ethical considerations and the difficulty of translating laboratory discoveries into reliable real-world applications.

Conclusion

Biotechnology companies sit at the intersection of biology, medicine, engineering, computing and industrial science. Their work can range from studying genes and proteins to developing advanced cell therapies, agricultural technologies, biological manufacturing systems and environmental solutions.

The sector is changing rapidly as genome editing, RNA technologies, synthetic biology, automation and AI converge. At the same time, important challenges remain around scientific validation, delivery, manufacturing, safety, regulation and responsible use.

The most significant future developments may come not from one technology alone, but from combining biological research with increasingly capable computational and engineering systems.

For anyone studying the biotechnology industry, understanding this combination of research, technology, applications and regulation provides a useful foundation for following the sector's continuing development.

Disclaimer

This article is provided for general educational and informational purposes only. It is not intended as medical, scientific, regulatory, legal or professional advice, and it does not endorse any particular biotechnology company, technology or biological product. Biotechnology research and regulatory requirements can change rapidly, and readers should consult authoritative scientific publications, regulatory agencies and qualified professionals for decisions involving healthcare, laboratory research, genetic technologies, clinical development or biosafety.